P.07.36 REAL-WORLD EVIDENCE OF VEDOLIZUMAB THERAPY IN ULCERATIVE COLITIS AND CROHN'S DISEASE PATIENTS: FECAL CALPROTECTIN A VALID BIOMARKER OF MUCOSAL INFLAMMATION. (25th March 2019)

Record Type:: Journal Article
Title:: P.07.36 REAL-WORLD EVIDENCE OF VEDOLIZUMAB THERAPY IN ULCERATIVE COLITIS AND CROHN'S DISEASE PATIENTS: FECAL CALPROTECTIN A VALID BIOMARKER OF MUCOSAL INFLAMMATION. (25th March 2019)
Main Title:: P.07.36 REAL-WORLD EVIDENCE OF VEDOLIZUMAB THERAPY IN ULCERATIVE COLITIS AND CROHN'S DISEASE PATIENTS: FECAL CALPROTECTIN A VALID BIOMARKER OF MUCOSAL INFLAMMATION
Authors:: Cicerone, C.
Luppino, I.
Erboso, M.
Paese, P.
Leo, P.
Abstract:
Is Part Of:: Digestive and liver disease. Volume 51(2019)Supplement 2
Journal:: Digestive and liver disease
Issue:: Volume 51(2019)Supplement 2
Issue Display:: Volume 51, Issue 2 (2019)
Year:: 2019
Volume:: 51
Issue:: 2
Issue Sort Value:: 2019-0051-0002-0000
Page Start:: e239
Page End:
Publication Date:: 2019-03-25
Subjects:: Digestive organs -- Diseases -- Periodicals
Liver -- Diseases -- Periodicals
616.33005
Journal URLs:: http://www.sciencedirect.com/science/journal/15908658 ↗
http://www.elsevier.com/journals ↗
DOI:: 10.1016/S1590-8658(19)30485-2 ↗
Languages:: English
ISSNs:: 1590-8658
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 3588.345600
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:: 9725.xml